Click here to download our latest Newsletter
Read more...Posts Tagged: gastrointestinal tract
- AMMF’s Hybrid 2023 European Cholangiocarcinoma Conference
- 2021 Conference Programme
- A step towards more effective treatments …
- ABC-07 (SBRT)
- ABC-09 (EORTC-1607-GITCG)
- About AMMF – The Cholangiocarcinoma Charity
- ACTICCA-1
- adidas Silverstone Half Marathon – Sunday 6th March, 2011
- Aintree University Hospital, Liverpool
- Alphabetical Photo Page
- Ambassadors
- Amble for AMMF – Keeping it Legal
- Amble for AMMF 2016
- AMMF 6-page leaflet
- AMMF asks Scottish Parliament to Rethink Liver Cancer
- AMMF BBC Devon TV Interview with Mark & Terry Matthews
- AMMF calls for a Fairer Deal, Faster in Westminster
- AMMF CCA Conference 2019 – Speakers
- AMMF CCA Conference 2019 – the event in images
- AMMF CCA Conference 2022 – the event in images
- AMMF Cholangiocarcinoma Conference 2017
- AMMF Cholangiocarcinoma Conference 2018
- AMMF Cholangiocarcinoma Conference 2018 – Speakers
- AMMF Cholangiocarcinoma Conference 2019
- AMMF European Cholangiocarcinoma Website
- AMMF fundraising activities
- AMMF Grants for Research
- AMMF Research Grants – Applications
- AMMF Shop
- AMMF Slimathon- Losing weight and Gaining Pounds for AMMF!
- AMMF Summer Ball 2010
- AMMF welcomes our Thai Delegation
- AMMF’s Cholangiocarcinoma Conference 2019 Full details and FAQs
- AMMF’s Conference, Thursday 11 May 2017
- AMMF’s Conferences over the years …
- AMMF’s Discussion Groups
- AMMF’s Facebook Guest Posts 2017
- AMMF’s Hybrid 2022 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2024 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2025 European Cholangiocarcinoma Conference
- AMMF CCA Conference 2025 – The event in images
- AMMF’s Hybrid 2025 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2025 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2025 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2025 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2025 European Cholangiocarcinoma Conference
- AMMF’s Hybrid 2025 European Cholangiocarcinoma Conference
- Poster Presentations 2025
- AMMF’s position on the use of animals in research
- AMMF’s Top Fundraising Tips
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s Virtual 2021 European Cholangiocarcinoma Conference – Video Archive
- AMMF’s White Paper is launched in Westminster
- Angiogram
- ARTEMIDE-Biliary01
- Asp-PSC – a study for those with primary sclerosing cholangitis (PSC)
- Basket
- Biomarker BI-010 looks promising …
- Biopsy
- Birmingham University
- CAF – Matched Giving and Give as you Earn Schemes (for employers and employees)
- Call for Abstracts
- Call for Abstracts 2025
- Cancer Research UK / The BILCAP Trial
- Causes and risk factors
- CC Day 1 – Guest Post from Helen Tanner
- CC Day 10 – Guest Post by Colette Valentine
- CC Day 11 – Tribute to Amanda Lofting
- CC Day 12 – Guest Post by Clare Henderson & Kirsty Mackay
- CC Day 13 – Guest Post by Sophie Culshaw
- CC Day 14 – Guest Post by Rachael Cornish
- CC Day 15 – Guest Post by Aleisha and Thomas Gray
- CC Day 16 – Guest Post by Claire Johnson
- CC Day 17 – Guest Post by Brian Russell
- CC Day 18 – Guest Post by Kaz Molloy
- CC Day 19 – Guest Post by Laura Flett
- CC Day 2 – Guest Post by Rebecca West
- CC Day 20 – Guest Post by Liam Crossley
- CC Day 21 – Guest Post by Karen Finlinson
- CC Day 22 – Guest Post by Bernie Podmore & Gerry Hatheralll
- CC Day 23 – Guest Post by Victoria Carney
- CC Day 24 – Guest Post by Andrea Sheardown
- CC Day 25 – Guest Post by Hedli Niklaus
- CC Day 26 – Guest Post by Nikki Greenall
- CC Day 27 – Guest Post by Amelia Andrews
- CC Day 28 – Guest Post by Beryl Jones
- CC Day 3 – Guest Post by Ben Francis
- CC Day 4 – Guest Post by Thomas Barker
- CC Day 5 – Guest Post by Vikki Stokes
- CC Day 6 – Guest Post by Shirley Turton
- CC Day 7 – Guest Post by Matthew Burns
- CC Day 8 – Guest Post by Claire Bradburn
- CC Day 9 – Guest Post by Natalie Meikle
- Checkout → Pay
- Cholangiocarcinoma Awareness Month
- Cholangiocarcinoma Awareness Month – February 2014
- Cholangiocarcinoma Awareness Month – February 2015
- Cholangiocarcinoma Awareness Month
My CCA Story - Cholangiocarcinoma Defined
- Choledochal cysts
- Collaboration & Cooperation
- Cookie Policy
- Corporate support
- Current Cholangiocarcinoma Trials
- Current trials no longer recruiting
- DETERMINE
- Diagnosis and Staging
- Disclaimer
- Discussion Forum
- Discussion forum Enquiries
- Efficacy and Safety of Zanidatamab with Standard-of-care Therapy against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- ERCP (endoscopic retrograde cholangiopancreatography)
- Fast Facts for those with Cholangiocarcinoma
- FIGHT-207
- FIGHT-302
- FIRST-308
- Forum Terms and Conditions
- Fundraising Enquiries
- General Enquiries
- Get Involved: Fundraise for AMMF and Make a Difference
- Giving in Memory
- GP Awareness Campaign 2025
- Grant for ICC Research
- Guidelines for the Diagnosis and Management of Cholangiocarcinoma
- Helpful Links on the topics of Dying and Bereavement
- Home
- Ignyta STARTRK-2
- Imperial College
- Imperial College London
- Imperial College London
- Imperial College London
- Imperial College London
- Inaugural CCA-UK Meeting, 07 December, 2018
- Info and FAQ’s
- Institute of Genetics & Molecular Medicine
- Institute of Hepatology
- Institute of Hepatology
- International Centres
- International patients requesting medical treatment in the UK
- Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Patients With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma
- John’s Biomarker Award
- Laparoscopy
- Latest News
- Latest Topics
- Leaving a Gift in your Will
- Logout
- Making a Will
- Medical/Clinical Advisors
- Meeting with CRUK re BILCAP
- Molecular Profiling and Targeted Therapies
- Molecular Profiling, Targeted Therapies and Immunotherapy – updates
- Molecular Profiling: booklet and video
- MRI (magnetic resonance imaging)
- My Account
- New Genetic Research
- News
- NuTide:121
- Nutrition
- Online shop Enquiries
- Order Received
- Other CChallenges …
- Other recent runs
- Other ways to get involved
- Our CCA Family
- Our CCA Family – Your Story
- Our Literature
- Palliative care
- Paris Marathon 2010
- Patient Guide in Biliary Tract Cancer
- Patient Information sheets
- Patient Organisation Cholangiocarcinoma Education Resources
- Patient Resources
- Patient Webinars
- PCI and Chemotherapy
- PET (positron emission tomography)
- photo
- Preparing for the death of a terminally ill loved one: What to expect
- Privacy Statement
- PTC (percutaneous transhepatic cholangiography)
- Questions to ask your Doctor
- Quiz Nights
- Radiotherapy
- Recently completed grants
- Referral information
- Reports
- Research Updates
- Rethink Liver Cancer 2024
- Rethink Liver Cancer 2025
- Rethink Liver Cancer Parliamentary Receptions
- SAFIR ABC-10
- Scientific Advisors
- Second opinions and liver disease centres
- Sending or transferring funds to AMMF
- Speakers at AMMF’s Cholangiocarcinoma Conference 2017
- Specialist Viewpoint
- Specialist Viewpoint
- Specialist Viewpoint
Cholangiocarcinoma – An overview - Specialist Viewpoint
Cholangiocarcinoma – An overview - Specialist Viewpoint
Demystifying the MDT - Specialist Viewpoint
Pathology - Sponsorship opportunities are available
- Sporting events
- Staging
- Staging Cholangiocarcinoma
- Stent insertion
- Stop cholangiocarcinoma striking before it’s too late
- Surgery
- Surgery for Cholangiocarcinoma, and why it may not be possible
- Symptoms
- Take the CChallenge!
- Terry and Mark’s BBC interview
- Thank you
- The “Say it, Share it, Send it!” campaign
- The ABC-12 Study
- The BILCAP Trial
- The day in pictures
- The day unfolds
- The Faces of Cholangiocarcinoma 2025
- The Rethink Liver Cancer White Paper
- The SIRCCA Trial
- The TAS120-101 trial
- The University of Manchester
- The University of Oxford
- The Work of AMMF – An Overview
- Treatment options
- Trials in set up
- Trustees
- University College London
- University College London
- University of East Anglia
- University of Edinburgh
- University of Liverpool
- University of Nottingham
- Upcoming
- User Avatar
- Vacancies
- Virgin London Marathon – Sunday 22nd April 2012
- Virgin London Marathon 2010
- What is Cholangiocarcinoma?
- What is Cholangiocarcinoma?
- What you said
- World Cholangiocarcinoma Day
- Grants Made
- Donate to AMMF
- Helpful Links
- Introduction to Cholangiocarcinoma
- Contact Us
